Matches in Wikidata for { <http://www.wikidata.org/entity/Q92673253> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q92673253 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92673253 description "scientific article published on 03 August 2019" @default.
- Q92673253 description "wetenschappelijk artikel" @default.
- Q92673253 description "наукова стаття, опублікована 3 серпня 2019" @default.
- Q92673253 name "Galantamine to reduce relapse after agonist taper for individuals with opioid use disorder" @default.
- Q92673253 name "Galantamine to reduce relapse after agonist taper for individuals with opioid use disorder" @default.
- Q92673253 type Item @default.
- Q92673253 label "Galantamine to reduce relapse after agonist taper for individuals with opioid use disorder" @default.
- Q92673253 label "Galantamine to reduce relapse after agonist taper for individuals with opioid use disorder" @default.
- Q92673253 prefLabel "Galantamine to reduce relapse after agonist taper for individuals with opioid use disorder" @default.
- Q92673253 prefLabel "Galantamine to reduce relapse after agonist taper for individuals with opioid use disorder" @default.
- Q92673253 P1433 Q92673253-4D5C4109-20AA-4FA2-AC42-9ABC6CC9DF83 @default.
- Q92673253 P1476 Q92673253-729437AC-B8C7-4F43-A8C2-2873AB0910CB @default.
- Q92673253 P2093 Q92673253-27B7DAF8-3CF6-4B11-9D75-F4F6CE0CC8D4 @default.
- Q92673253 P2093 Q92673253-62DC8A99-E61A-4830-8E53-3CDD554D7E8D @default.
- Q92673253 P2093 Q92673253-795B048E-1FDB-4D2E-8B00-EDCA4839E08B @default.
- Q92673253 P304 Q92673253-E78ED059-EC45-4777-8BC5-8A1096ADCBC3 @default.
- Q92673253 P31 Q92673253-042604F6-55A8-403C-9337-C5392D55B648 @default.
- Q92673253 P356 Q92673253-07903FF0-CC8A-4B47-8425-D50D3DEE2068 @default.
- Q92673253 P478 Q92673253-3C6B674F-1CBD-4344-A0EA-248F1DB7A5E5 @default.
- Q92673253 P577 Q92673253-8AEA5154-B29F-415F-8C01-C019A4828117 @default.
- Q92673253 P698 Q92673253-C2A82298-097F-484F-9FE6-29D00B8130C5 @default.
- Q92673253 P921 Q92673253-9963532F-3E98-4FF3-BC09-66F3C972DA9B @default.
- Q92673253 P921 Q92673253-DE0EF2AF-66FB-4EE0-BC7B-2FCF4E279980 @default.
- Q92673253 P356 J.DRUGALCDEP.2019.05.013 @default.
- Q92673253 P698 31421476 @default.
- Q92673253 P1433 Q5308875 @default.
- Q92673253 P1476 "Galantamine to reduce relapse after agonist taper for individuals with opioid use disorder" @default.
- Q92673253 P2093 "Julia M Shi" @default.
- Q92673253 P2093 "Kathleen M Carroll" @default.
- Q92673253 P2093 "Mehmet Sofuoglu" @default.
- Q92673253 P304 "98" @default.
- Q92673253 P31 Q13442814 @default.
- Q92673253 P356 "10.1016/J.DRUGALCDEP.2019.05.013" @default.
- Q92673253 P478 "203" @default.
- Q92673253 P577 "2019-08-03T00:00:00Z" @default.
- Q92673253 P698 "31421476" @default.
- Q92673253 P921 Q1639178 @default.
- Q92673253 P921 Q7632070 @default.